Global Biosimilars/follow-on-biologics Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Biosimilars/follow-on-biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Biosimilars/follow-on-biologics market size is estimated to be worth US$ 9560.2 million in 2021 and is forecast to a readjusted size of USD 11700 million by 2028 with a CAGR of 2.9% during review period. Blood Disorders accounting for % of the Biosimilars/follow-on-biologics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Human growth hormone segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Biosimilars/follow-on-biologics include Novartis (Sandoz), Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, and Celltrion Biocon, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biosimilars/follow-on-biologics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
Market segment by Application, can be divided into
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
Market segment by players, this report covers
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biosimilars/follow-on-biologics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biosimilars/follow-on-biologics, with revenue, gross margin and global market share of Biosimilars/follow-on-biologics from 2019 to 2022.
Chapter 3, the Biosimilars/follow-on-biologics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biosimilars/follow-on-biologics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biosimilars/follow-on-biologics research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Biosimilars/follow-on-biologics
1.2 Classification of Biosimilars/follow-on-biologics by Type
1.2.1 Overview: Global Biosimilars/follow-on-biologics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Type in 2021
1.2.3 Human growth hormone
1.2.4 Erythropoietin
1.2.5 Monoclonal antibodies
1.2.6 Insulin
1.2.7 Interferon
1.2.8 Granulocyte-Colony Stimulating Factor
1.2.9 Others
1.3 Global Biosimilars/follow-on-biologics Market by Application
1.3.1 Overview: Global Biosimilars/follow-on-biologics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.3.4 Chronic and Autoimmune Diseases
1.3.5 Growth Hormone Deficiencies
1.3.6 Others
1.4 Global Biosimilars/follow-on-biologics Market Size & Forecast
1.5 Global Biosimilars/follow-on-biologics Market Size and Forecast by Region
1.5.1 Global Biosimilars/follow-on-biologics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Biosimilars/follow-on-biologics Market Size by Region, (2017-2022)
1.5.3 North America Biosimilars/follow-on-biologics Market Size and Prospect (2017-2028)
1.5.4 Europe Biosimilars/follow-on-biologics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Biosimilars/follow-on-biologics Market Size and Prospect (2017-2028)
1.5.6 South America Biosimilars/follow-on-biologics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Biosimilars/follow-on-biologics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biosimilars/follow-on-biologics Market Drivers
1.6.2 Biosimilars/follow-on-biologics Market Restraints
1.6.3 Biosimilars/follow-on-biologics Trends Analysis
2 Company Profiles
2.1 Novartis (Sandoz)
2.1.1 Novartis (Sandoz) Details
2.1.2 Novartis (Sandoz) Major Business
2.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Product and Solutions
2.1.4 Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Novartis (Sandoz) Recent Developments and Future Plans
2.2 Synthon Pharmaceuticals
2.2.1 Synthon Pharmaceuticals Details
2.2.2 Synthon Pharmaceuticals Major Business
2.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product and Solutions
2.2.4 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Synthon Pharmaceuticals Recent Developments and Future Plans
2.3 Teva Pharmaceutical Industries
2.3.1 Teva Pharmaceutical Industries Details
2.3.2 Teva Pharmaceutical Industries Major Business
2.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product and Solutions
2.3.4 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
2.4 LG Life Sciences
2.4.1 LG Life Sciences Details
2.4.2 LG Life Sciences Major Business
2.4.3 LG Life Sciences Biosimilars/follow-on-biologics Product and Solutions
2.4.4 LG Life Sciences Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 LG Life Sciences Recent Developments and Future Plans
2.5 Celltrion Biocon
2.5.1 Celltrion Biocon Details
2.5.2 Celltrion Biocon Major Business
2.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Product and Solutions
2.5.4 Celltrion Biocon Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Celltrion Biocon Recent Developments and Future Plans
2.6 Hospira
2.6.1 Hospira Details
2.6.2 Hospira Major Business
2.6.3 Hospira Biosimilars/follow-on-biologics Product and Solutions
2.6.4 Hospira Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Hospira Recent Developments and Future Plans
2.7 Merck Serono (Merck)
2.7.1 Merck Serono (Merck) Details
2.7.2 Merck Serono (Merck) Major Business
2.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Product and Solutions
2.7.4 Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Merck Serono (Merck) Recent Developments and Future Plans
2.8 Biogen idec
2.8.1 Biogen idec Details
2.8.2 Biogen idec Major Business
2.8.3 Biogen idec Biosimilars/follow-on-biologics Product and Solutions
2.8.4 Biogen idec Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Biogen idec Recent Developments and Future Plans
2.9 Genentech (Roche)
2.9.1 Genentech (Roche) Details
2.9.2 Genentech (Roche) Major Business
2.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Product and Solutions
2.9.4 Genentech (Roche) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Genentech (Roche) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biosimilars/follow-on-biologics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Biosimilars/follow-on-biologics Players Market Share in 2021
3.2.2 Top 10 Biosimilars/follow-on-biologics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Biosimilars/follow-on-biologics Players Head Office, Products and Services Provided
3.4 Biosimilars/follow-on-biologics Mergers & Acquisitions
3.5 Biosimilars/follow-on-biologics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biosimilars/follow-on-biologics Revenue and Market Share by Type (2017-2022)
4.2 Global Biosimilars/follow-on-biologics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Biosimilars/follow-on-biologics Revenue Market Share by Application (2017-2022)
5.2 Global Biosimilars/follow-on-biologics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Biosimilars/follow-on-biologics Revenue by Type (2017-2028)
6.2 North America Biosimilars/follow-on-biologics Revenue by Application (2017-2028)
6.3 North America Biosimilars/follow-on-biologics Market Size by Country
6.3.1 North America Biosimilars/follow-on-biologics Revenue by Country (2017-2028)
6.3.2 United States Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
6.3.3 Canada Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
6.3.4 Mexico Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Biosimilars/follow-on-biologics Revenue by Type (2017-2028)
7.2 Europe Biosimilars/follow-on-biologics Revenue by Application (2017-2028)
7.3 Europe Biosimilars/follow-on-biologics Market Size by Country
7.3.1 Europe Biosimilars/follow-on-biologics Revenue by Country (2017-2028)
7.3.2 Germany Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
7.3.3 France Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
7.3.5 Russia Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
7.3.6 Italy Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biosimilars/follow-on-biologics Revenue by Type (2017-2028)
8.2 Asia-Pacific Biosimilars/follow-on-biologics Revenue by Application (2017-2028)
8.3 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region
8.3.1 Asia-Pacific Biosimilars/follow-on-biologics Revenue by Region (2017-2028)
8.3.2 China Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
8.3.3 Japan Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
8.3.4 South Korea Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
8.3.5 India Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
8.3.7 Australia Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Biosimilars/follow-on-biologics Revenue by Type (2017-2028)
9.2 South America Biosimilars/follow-on-biologics Revenue by Application (2017-2028)
9.3 South America Biosimilars/follow-on-biologics Market Size by Country
9.3.1 South America Biosimilars/follow-on-biologics Revenue by Country (2017-2028)
9.3.2 Brazil Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
9.3.3 Argentina Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biosimilars/follow-on-biologics Revenue by Type (2017-2028)
10.2 Middle East & Africa Biosimilars/follow-on-biologics Revenue by Application (2017-2028)
10.3 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country
10.3.1 Middle East & Africa Biosimilars/follow-on-biologics Revenue by Country (2017-2028)
10.3.2 Turkey Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
10.3.4 UAE Biosimilars/follow-on-biologics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Biosimilars/follow-on-biologics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Biosimilars/follow-on-biologics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Biosimilars/follow-on-biologics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Biosimilars/follow-on-biologics Revenue Market Share by Region (2023-2028)
Table 6. Novartis (Sandoz) Corporate Information, Head Office, and Major Competitors
Table 7. Novartis (Sandoz) Major Business
Table 8. Novartis (Sandoz) Biosimilars/follow-on-biologics Product and Solutions
Table 9. Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Synthon Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 11. Synthon Pharmaceuticals Major Business
Table 12. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product and Solutions
Table 13. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Teva Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors
Table 15. Teva Pharmaceutical Industries Major Business
Table 16. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product and Solutions
Table 17. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. LG Life Sciences Corporate Information, Head Office, and Major Competitors
Table 19. LG Life Sciences Major Business
Table 20. LG Life Sciences Biosimilars/follow-on-biologics Product and Solutions
Table 21. LG Life Sciences Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Celltrion Biocon Corporate Information, Head Office, and Major Competitors
Table 23. Celltrion Biocon Major Business
Table 24. Celltrion Biocon Biosimilars/follow-on-biologics Product and Solutions
Table 25. Celltrion Biocon Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Hospira Corporate Information, Head Office, and Major Competitors
Table 27. Hospira Major Business
Table 28. Hospira Biosimilars/follow-on-biologics Product and Solutions
Table 29. Hospira Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Merck Serono (Merck) Corporate Information, Head Office, and Major Competitors
Table 31. Merck Serono (Merck) Major Business
Table 32. Merck Serono (Merck) Biosimilars/follow-on-biologics Product and Solutions
Table 33. Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Biogen idec Corporate Information, Head Office, and Major Competitors
Table 35. Biogen idec Major Business
Table 36. Biogen idec Biosimilars/follow-on-biologics Product and Solutions
Table 37. Biogen idec Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Genentech (Roche) Corporate Information, Head Office, and Major Competitors
Table 39. Genentech (Roche) Major Business
Table 40. Genentech (Roche) Biosimilars/follow-on-biologics Product and Solutions
Table 41. Genentech (Roche) Biosimilars/follow-on-biologics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Biosimilars/follow-on-biologics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Biosimilars/follow-on-biologics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Biosimilars/follow-on-biologics Players Head Office, Products and Services Provided
Table 46. Biosimilars/follow-on-biologics Mergers & Acquisitions in the Past Five Years
Table 47. Biosimilars/follow-on-biologics New Entrants and Expansion Plans
Table 48. Global Biosimilars/follow-on-biologics Revenue (USD Million) by Type (2017-2022)
Table 49. Global Biosimilars/follow-on-biologics Revenue Share by Type (2017-2022)
Table 50. Global Biosimilars/follow-on-biologics Revenue Forecast by Type (2023-2028)
Table 51. Global Biosimilars/follow-on-biologics Revenue by Application (2017-2022)
Table 52. Global Biosimilars/follow-on-biologics Revenue Forecast by Application (2023-2028)
Table 53. North America Biosimilars/follow-on-biologics Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Biosimilars/follow-on-biologics Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Biosimilars/follow-on-biologics Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Biosimilars/follow-on-biologics Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Biosimilars/follow-on-biologics Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Biosimilars/follow-on-biologics Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Biosimilars/follow-on-biologics Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Biosimilars/follow-on-biologics Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Biosimilars/follow-on-biologics Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Biosimilars/follow-on-biologics Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Biosimilars/follow-on-biologics Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Biosimilars/follow-on-biologics Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Biosimilars/follow-on-biologics Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Biosimilars/follow-on-biologics Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Biosimilars/follow-on-biologics Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Biosimilars/follow-on-biologics Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Biosimilars/follow-on-biologics Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Biosimilars/follow-on-biologics Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Biosimilars/follow-on-biologics Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Biosimilars/follow-on-biologics Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Biosimilars/follow-on-biologics Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Biosimilars/follow-on-biologics Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Biosimilars/follow-on-biologics Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Biosimilars/follow-on-biologics Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Biosimilars/follow-on-biologics Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Biosimilars/follow-on-biologics Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Biosimilars/follow-on-biologics Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Biosimilars/follow-on-biologics Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Biosimilars/follow-on-biologics Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Biosimilars/follow-on-biologics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Biosimilars/follow-on-biologics Picture
Figure 2. Global Biosimilars/follow-on-biologics Revenue Market Share by Type in 2021
Figure 3. Human growth hormone
Figure 4. Erythropoietin
Figure 5. Monoclonal antibodies
Figure 6. Insulin
Figure 7. Interferon
Figure 8. Granulocyte-Colony Stimulating Factor
Figure 9. Others
Figure 10. Biosimilars/follow-on-biologics Revenue Market Share by Application in 2021
Figure 11. Blood Disorders Picture
Figure 12. Oncology Diseases Picture
Figure 13. Chronic and Autoimmune Diseases Picture
Figure 14. Growth Hormone Deficiencies Picture
Figure 15. Others Picture
Figure 16. Global Biosimilars/follow-on-biologics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 17. Global Biosimilars/follow-on-biologics Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Biosimilars/follow-on-biologics Revenue Market Share by Region (2017-2028)
Figure 19. Global Biosimilars/follow-on-biologics Revenue Market Share by Region in 2021
Figure 20. North America Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Europe Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Asia-Pacific Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. South America Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. Middle East and Africa Biosimilars/follow-on-biologics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 25. Biosimilars/follow-on-biologics Market Drivers
Figure 26. Biosimilars/follow-on-biologics Market Restraints
Figure 27. Biosimilars/follow-on-biologics Market Trends
Figure 28. Novartis (Sandoz) Recent Developments and Future Plans
Figure 29. Synthon Pharmaceuticals Recent Developments and Future Plans
Figure 30. Teva Pharmaceutical Industries Recent Developments and Future Plans
Figure 31. LG Life Sciences Recent Developments and Future Plans
Figure 32. Celltrion Biocon Recent Developments and Future Plans
Figure 33. Hospira Recent Developments and Future Plans
Figure 34. Merck Serono (Merck) Recent Developments and Future Plans
Figure 35. Biogen idec Recent Developments and Future Plans
Figure 36. Genentech (Roche) Recent Developments and Future Plans
Figure 37. Global Biosimilars/follow-on-biologics Revenue Share by Players in 2021
Figure 38. Biosimilars/follow-on-biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Biosimilars/follow-on-biologics Revenue Market Share in 2021
Figure 40. Global Top 10 Players Biosimilars/follow-on-biologics Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Biosimilars/follow-on-biologics Revenue Share by Type in 2021
Figure 43. Global Biosimilars/follow-on-biologics Market Share Forecast by Type (2023-2028)
Figure 44. Global Biosimilars/follow-on-biologics Revenue Share by Application in 2021
Figure 45. Global Biosimilars/follow-on-biologics Market Share Forecast by Application (2023-2028)
Figure 46. North America Biosimilars/follow-on-biologics Sales Market Share by Type (2017-2028)
Figure 47. North America Biosimilars/follow-on-biologics Sales Market Share by Application (2017-2028)
Figure 48. North America Biosimilars/follow-on-biologics Revenue Market Share by Country (2017-2028)
Figure 49. United States Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Biosimilars/follow-on-biologics Sales Market Share by Type (2017-2028)
Figure 53. Europe Biosimilars/follow-on-biologics Sales Market Share by Application (2017-2028)
Figure 54. Europe Biosimilars/follow-on-biologics Revenue Market Share by Country (2017-2028)
Figure 55. Germany Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Biosimilars/follow-on-biologics Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Biosimilars/follow-on-biologics Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Biosimilars/follow-on-biologics Revenue Market Share by Region (2017-2028)
Figure 63. China Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Biosimilars/follow-on-biologics Sales Market Share by Type (2017-2028)
Figure 70. South America Biosimilars/follow-on-biologics Sales Market Share by Application (2017-2028)
Figure 71. South America Biosimilars/follow-on-biologics Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Biosimilars/follow-on-biologics Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Biosimilars/follow-on-biologics Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Biosimilars/follow-on-biologics Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Biosimilars/follow-on-biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
